187 related articles for article (PubMed ID: 4705407)
1. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
Man'kovskii NB; Vainshtok AB; Oleinik LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
[No Abstract] [Full Text] [Related]
2. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
[No Abstract] [Full Text] [Related]
3. [Catecholamine excretion and treatment of parkinsonism with midantan].
Kandel' EI; Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
[No Abstract] [Full Text] [Related]
4. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
5. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
Evtushenko SK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
[TBL] [Abstract][Full Text] [Related]
6. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
Kadykov AS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):174-8. PubMed ID: 944514
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of the Parkinson syndrome with amantadine].
Hartmann-von Monakow K
Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
[No Abstract] [Full Text] [Related]
8. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
Antonini FM; Baroni A
Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
[No Abstract] [Full Text] [Related]
9. Combined treatment of parkinsonism with L-dopa and amantadine.
Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
[No Abstract] [Full Text] [Related]
10. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
Appleton DB; Eadie MJ; Sutherland JM
Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
[No Abstract] [Full Text] [Related]
11. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
12. [Amantadine and dexetimide in the treatment of parkinsonism].
Hakkarainen H; Viukari M
Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
[No Abstract] [Full Text] [Related]
13. [Combined use of metamizil and midantan in vascular parkinsonism].
Kamenetskiĭ VK
Klin Med (Mosk); 1979 Sep; 57(9):59-62. PubMed ID: 491516
[No Abstract] [Full Text] [Related]
14. [On the action of amantadine in postencephalitic parkinsonism].
Pennacchietti M; Aletto PM
Minerva Med; 1971 Oct; 62(82):3960-2. PubMed ID: 5125052
[No Abstract] [Full Text] [Related]
15. [Long-term effects of amantadine in striatal syndromes].
Rovetta P
Minerva Med; 1971 Oct; 62(82):3965-7. PubMed ID: 5125054
[No Abstract] [Full Text] [Related]
16. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
[No Abstract] [Full Text] [Related]
17. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
[No Abstract] [Full Text] [Related]
18. [Amantadine treatment in parkinsonism].
Holmsen R
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984
[No Abstract] [Full Text] [Related]
19. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
20. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
